Fabrication of aptamer-guided siRNA loaded lipopolyplexes for gene silencing of notch 1 in MDA-mb-231 triple negative breast cancer cell line
出版年份 2021 全文链接
标题
Fabrication of aptamer-guided siRNA loaded lipopolyplexes for gene silencing of notch 1 in MDA-mb-231 triple negative breast cancer cell line
作者
关键词
siRNA, Breast cancer, Lipopolyplex, Aptamer, siRNA delivery, Notch 1
出版物
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
Volume 65, Issue -, Pages 102733
出版商
Elsevier BV
发表日期
2021-07-17
DOI
10.1016/j.jddst.2021.102733
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Targeted drug delivery strategies for precision medicines
- (2021) Mandana T. Manzari et al. Nature Reviews Materials
- siRNA: Mechanism of action, challenges, and therapeutic approaches
- (2021) Walhan Alshaer et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy
- (2021) Chiara Brignole et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Carcinogenesis of Triple-Negative Breast Cancer and Sex Steroid Hormones
- (2021) Naoko Honma et al. Cancers
- Recent advancements in liposome technology
- (2020) Nina Filipczak et al. ADVANCED DRUG DELIVERY REVIEWS
- Co-delivery of EGFR and BRD4 siRNA by cell-penetrating peptides-modified redox-responsive complex in triple negative breast cancer cells
- (2020) Chi Zhang et al. LIFE SCIENCES
- Breast Cancer Treatment
- (2019) Adrienne G. Waks et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Drugging an undruggable pocket on KRAS
- (2019) Dirk Kessler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Notch Signaling Activation as a Hallmark for Triple-Negative Breast Cancer Subtype
- (2019) M. V. Giuli et al. Journal of Oncology
- Aptamer-guided siRNA-loaded nanomedicines for systemic gene silencing in CD-44 expressing murine triple-negative breast cancer model
- (2018) Walhan Alshaer et al. JOURNAL OF CONTROLLED RELEASE
- Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems
- (2018) M. Danaei et al. Pharmaceutics
- Silencing the roadblocks to effective triple-negative breast cancer treatments by siRNA nanoparticles
- (2017) Jenny G Parvani et al. ENDOCRINE-RELATED CANCER
- The Effects of Spacer Length and Composition on Aptamer-Mediated Cell-Specific Targeting with Nanoscale PEGylated Liposomal Doxorubicin
- (2016) Hang Xing et al. CHEMBIOCHEM
- Low molecular weight chitosan–protamine conjugate for siRNA delivery with enhanced stability and transfection efficiency
- (2016) Sushilkumar Patil et al. RSC Advances
- Nucleolin overexpression in breast cancer cell sub-populations with different stem-like phenotype enables targeted intracellular delivery of synergistic drug combination
- (2015) Nuno A. Fonseca et al. BIOMATERIALS
- Liposomes as siRNA Delivery Vectors
- (2015) Sabrina Bochicchio et al. CURRENT DRUG METABOLISM
- Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model
- (2015) Elisabetta Benedetti et al. Oncotarget
- Aptamer-Mediated Up-conversion Core/MOF Shell Nanocomposites for Targeted Drug Delivery and Cell Imaging
- (2015) Kerong Deng et al. Scientific Reports
- Triple-Negative Breast Carcinoma
- (2014) Robert Schmadeka et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Influence of trypsinization and alternative procedures for cell preparation before RNA extraction on RNA integrity
- (2014) Peter Vrtačnik et al. ANALYTICAL BIOCHEMISTRY
- Functionalizing Liposomes with anti-CD44 Aptamer for Selective Targeting of Cancer Cells
- (2014) Walhan Alshaer et al. BIOCONJUGATE CHEMISTRY
- Notch-1 regulates proliferation and differentiation of human bladder cancer cell lines by inhibiting expression of Krüppel-like factor 4
- (2014) XING AI et al. ONCOLOGY REPORTS
- A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma
- (2013) Jonathan E. Rosenberg et al. INVESTIGATIONAL NEW DRUGS
- Selective delivery of an anticancer drug with aptamer-functionalized liposomes to breast cancer cells in vitro and in vivo
- (2013) Hang Xing et al. Journal of Materials Chemistry B
- Neuroblastoma-targeted Nanoparticles Entrapping siRNA Specifically Knockdown ALK
- (2011) Daniela Di Paolo et al. MOLECULAR THERAPY
- Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects
- (2010) Kazuo Maruyama ADVANCED DRUG DELIVERY REVIEWS
- A New Paradigm for Aptamer Therapeutic AS1411 Action: Uptake by Macropinocytosis and Its Stimulation by a Nucleolin-Dependent Mechanism
- (2010) E. M. Reyes-Reyes et al. CANCER RESEARCH
- The role of carrier size in the pharmacodynamics of antisense and siRNA oligonucleotides
- (2010) Leaf Huang et al. JOURNAL OF DRUG TARGETING
- Reversible Cell-Specific Drug Delivery with Aptamer-Functionalized Liposomes
- (2009) Zehui Cao et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Design of peptide-targeted liposomes containing nucleic acids
- (2009) Adriana O. Santos et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Origins and Mechanisms of miRNAs and siRNAs
- (2009) Richard W. Carthew et al. CELL
- The Nucleolin Targeting Aptamer AS1411 Destabilizes Bcl-2 Messenger RNA in Human Breast Cancer Cells
- (2008) S. Soundararajan et al. CANCER RESEARCH
- Chemically modified siRNA: tools and applications
- (2008) J WATTS et al. DRUG DISCOVERY TODAY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now